Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid
NOVA1
Reaktivität: Human
Wirt: Synthetic
BP, Imm
-
- Target Alle NOVA1 Produkte
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunogen (Imm)
- Sequenz
- REMPQNVAKT EPVS
- Produktmerkmale
- The peptide was used in the production of ABIN369762 - Goat Anti-NOVA1 Antibody. It is currently untested in blocking applications.
-
-
- Applikationshinweise
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
- Target
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Synonyme
- Nova-1 Peptide, NOVA1 Peptide, si:ch211-222c22.9 Peptide, 9430099M15Rik Peptide, G630039L02 Peptide, NOVA alternative splicing regulator 1 Peptide, neuro-oncological ventral antigen 1 L homeolog Peptide, neuro-oncological ventral antigen 1 Peptide, RNA-binding protein Nova-1 Peptide, lipid A export ATP-binding/permease protein Peptide, NOVA1 Peptide, Nova1 Peptide, nova1.L Peptide, nova1 Peptide, LOC790874 Peptide, novA1 Peptide
-
Sie sind hier:
